Eugia Pharma Discontinued
FDA Approved Drugs

Eugia Pharma Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 71
  • Latest Approval Date Jun 25, 2024
  • Data Source FDA
  • First Approval Date Apr 26, 1994
All
256
View
Unclassified
12
View
Discontinued
71
View
OTC
2
View
RX
171
View
Company Overview

Company

Eugia Pharma Discontinued

Country

India

Website

Visit Website

Email

info@eugia.co.in

Social Profiles

LinkedIn
Company Snapshot

Eugia Pharma Discontinued

Forming part of Sy No 83/1, Hyderabad Knowledge City TSIIC Raidurg, Panmaktha Plot, 1, Hitech City Rd, opp. IKEA Hyderabad, Telangana 500081

India

www.eugiapharma.com/ info@eugia.co.in View on Map
FDA Approved Drug Records ( 71 records )
2023
23 Jun
Discontinued Application: 210659

Drug Name

ALCAFTADINE

Product Number

1

Dosage Form

-

Strength

0.25%

Approval Date

2023-06-23

210659 / 1

Active Ingredient

ALCAFTADINE

Application Number

210659

Product Number

1

Dosage Form

-

Strength

0.25%

Approval Date

2023-06-23

Regulatory Status

Discontinued

2017
25 Oct
Discontinued Application: 204550

Drug Name

AMIODARONE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

50MG/ML

Approval Date

2017-10-25

204550 / 1

Active Ingredient

AMIODARONE HYDROCHLORIDE

Application Number

204550

Product Number

1

Dosage Form

-

Strength

50MG/ML

Approval Date

2017-10-25

Regulatory Status

Discontinued

2021
15 Oct
Discontinued Application: 214011

Drug Name

ARSENIC TRIOXIDE

Product Number

1

Dosage Form

-

Strength

2MG/ML

Approval Date

2021-10-15

214011 / 1

Active Ingredient

ARSENIC TRIOXIDE

Application Number

214011

Product Number

1

Dosage Form

-

Strength

2MG/ML

Approval Date

2021-10-15

Regulatory Status

Discontinued

2015
08 Apr
Discontinued Application: 206011

Drug Name

ATRACURIUM BESYLATE

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

2015-04-08

206011 / 1

Active Ingredient

ATRACURIUM BESYLATE

Application Number

206011

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

2015-04-08

Regulatory Status

Discontinued

2015
08 Apr
Discontinued Application: 206010

Drug Name

ATRACURIUM BESYLATE PRESERVATIVE FREE

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

2015-04-08

206010 / 1

Active Ingredient

ATRACURIUM BESYLATE

Application Number

206010

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

2015-04-08

Regulatory Status

Discontinued

2018
27 Jul
Discontinued Application: 205962

Drug Name

BIVALIRUDIN

Product Number

1

Dosage Form

-

Strength

250MG/VIAL

Approval Date

2018-07-27

205962 / 1

Active Ingredient

BIVALIRUDIN

Application Number

205962

Product Number

1

Dosage Form

-

Strength

250MG/VIAL

Approval Date

2018-07-27

Regulatory Status

Discontinued

2024
25 Jun
Discontinued Application: 215102

Drug Name

BUSULFAN

Product Number

1

Dosage Form

-

Strength

6MG/ML

Approval Date

2024-06-25

215102 / 1

Active Ingredient

BUSULFAN

Application Number

215102

Product Number

1

Dosage Form

-

Strength

6MG/ML

Approval Date

2024-06-25

Regulatory Status

Discontinued

2015
22 Sep
Discontinued Application: 205013

Drug Name

CAFFEINE CITRATE

Product Number

1

Dosage Form

-

Strength

EQ 30MG BASE/3ML (EQ 10MG BASE/ML)

Approval Date

2015-09-22

205013 / 1

Active Ingredient

CAFFEINE CITRATE

Application Number

205013

Product Number

1

Dosage Form

-

Strength

EQ 30MG BASE/3ML (EQ 10MG BASE/ML)

Approval Date

2015-09-22

Regulatory Status

Discontinued

2020
08 May
Discontinued Application: 209144

Drug Name

CISATRACURIUM BESYLATE

Product Number

1

Dosage Form

-

Strength

EQ 2MG BASE/ML

Approval Date

2020-05-08

209144 / 1

Active Ingredient

CISATRACURIUM BESYLATE

Application Number

209144

Product Number

1

Dosage Form

-

Strength

EQ 2MG BASE/ML

Approval Date

2020-05-08

Regulatory Status

Discontinued

2020
27 Oct
Discontinued Application: 209665

Drug Name

CISATRACURIUM BESYLATE PRESERVATIVE FREE

Product Number

1

Dosage Form

-

Strength

EQ 2MG BASE/ML

Approval Date

2020-10-27

209665 / 1

Active Ingredient

CISATRACURIUM BESYLATE

Application Number

209665

Product Number

1

Dosage Form

-

Strength

EQ 2MG BASE/ML

Approval Date

2020-10-27

Regulatory Status

Discontinued

2022
03 Oct
Discontinued Application: 212457

Drug Name

CLOFARABINE

Product Number

1

Dosage Form

-

Strength

20MG/20ML (1MG/ML)

Approval Date

2022-10-03

212457 / 1

Active Ingredient

CLOFARABINE

Application Number

212457

Product Number

1

Dosage Form

-

Strength

20MG/20ML (1MG/ML)

Approval Date

2022-10-03

Regulatory Status

Discontinued

1994
26 Apr
Discontinued Application: 74209

Drug Name

CROMOLYN SODIUM

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

1994-04-26

74209 / 1

Active Ingredient

CROMOLYN SODIUM

Application Number

74209

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

1994-04-26

Regulatory Status

Discontinued

2021
20 Sep
Discontinued Application: 214569

Drug Name

DECITABINE

Product Number

1

Dosage Form

-

Strength

50MG/VIAL

Approval Date

2021-09-20

214569 / 1

Active Ingredient

DECITABINE

Application Number

214569

Product Number

1

Dosage Form

-

Strength

50MG/VIAL

Approval Date

2021-09-20

Regulatory Status

Discontinued

2015
01 Dec
Discontinued Application: 206781

Drug Name

DEXAMETHASONE SODIUM PHOSPHATE

Product Number

1

Dosage Form

-

Strength

EQ 4MG PHOSPHATE/ML

Approval Date

2015-12-01

206781 / 1

Active Ingredient

DEXAMETHASONE SODIUM PHOSPHATE

Application Number

206781

Product Number

1

Dosage Form

-

Strength

EQ 4MG PHOSPHATE/ML

Approval Date

2015-12-01

Regulatory Status

Discontinued

2019
07 Jun
Discontinued Application: 210967

Drug Name

DEXAMETHASONE SODIUM PHOSPHATE

Product Number

1

Dosage Form

-

Strength

EQ 10MG PHOSPHATE/ML

Approval Date

2019-06-07

210967 / 1

Active Ingredient

DEXAMETHASONE SODIUM PHOSPHATE

Application Number

210967

Product Number

1

Dosage Form

-

Strength

EQ 10MG PHOSPHATE/ML

Approval Date

2019-06-07

Regulatory Status

Discontinued

2023
29 Mar
Discontinued Application: 216552

Drug Name

DILTIAZEM HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG/ML

Approval Date

2023-03-29

216552 / 1

Active Ingredient

DILTIAZEM HYDROCHLORIDE

Application Number

216552

Product Number

1

Dosage Form

-

Strength

5MG/ML

Approval Date

2023-03-29

Regulatory Status

Discontinued

2021
25 Jun
Discontinued Application: 214575

Drug Name

DOCETAXEL

Product Number

1

Dosage Form

-

Strength

20MG/2ML (10MG/ML)

Approval Date

2021-06-25

214575 / 1

Active Ingredient

DOCETAXEL

Application Number

214575

Product Number

1

Dosage Form

-

Strength

20MG/2ML (10MG/ML)

Approval Date

2021-06-25

Regulatory Status

Discontinued

2021
25 Jun
Discontinued Application: 214575

Drug Name

DOCETAXEL

Product Number

2

Dosage Form

-

Strength

80MG/8ML (10MG/ML)

Approval Date

2021-06-25

214575 / 2

Active Ingredient

DOCETAXEL

Application Number

214575

Product Number

2

Dosage Form

-

Strength

80MG/8ML (10MG/ML)

Approval Date

2021-06-25

Regulatory Status

Discontinued

2021
25 Jun
Discontinued Application: 214575

Drug Name

DOCETAXEL

Product Number

3

Dosage Form

-

Strength

160MG/16ML (10MG/ML)

Approval Date

2021-06-25

214575 / 3

Active Ingredient

DOCETAXEL

Application Number

214575

Product Number

3

Dosage Form

-

Strength

160MG/16ML (10MG/ML)

Approval Date

2021-06-25

Regulatory Status

Discontinued

2022
24 Jan
Discontinued Application: 213717

Drug Name

DOXERCALCIFEROL

Product Number

1

Dosage Form

-

Strength

2MCG/ML (2MCG/ML)

Approval Date

2022-01-24

213717 / 1

Active Ingredient

DOXERCALCIFEROL

Application Number

213717

Product Number

1

Dosage Form

-

Strength

2MCG/ML (2MCG/ML)

Approval Date

2022-01-24

Regulatory Status

Discontinued

2022
24 Jan
Discontinued Application: 213717

Drug Name

DOXERCALCIFEROL

Product Number

2

Dosage Form

-

Strength

4MCG/2ML (2MCG/ML)

Approval Date

2022-01-24

213717 / 2

Active Ingredient

DOXERCALCIFEROL

Application Number

213717

Product Number

2

Dosage Form

-

Strength

4MCG/2ML (2MCG/ML)

Approval Date

2022-01-24

Regulatory Status

Discontinued

2022
22 Jun
Discontinued Application: 216342

Drug Name

ERLOTINIB HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

2022-06-22

216342 / 1

Active Ingredient

ERLOTINIB HYDROCHLORIDE

Application Number

216342

Product Number

1

Dosage Form

-

Strength

EQ 25MG BASE

Approval Date

2022-06-22

Regulatory Status

Discontinued

2022
22 Jun
Discontinued Application: 216342

Drug Name

ERLOTINIB HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2022-06-22

216342 / 2

Active Ingredient

ERLOTINIB HYDROCHLORIDE

Application Number

216342

Product Number

2

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2022-06-22

Regulatory Status

Discontinued

2022
22 Jun
Discontinued Application: 216342

Drug Name

ERLOTINIB HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2022-06-22

216342 / 3

Active Ingredient

ERLOTINIB HYDROCHLORIDE

Application Number

216342

Product Number

3

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2022-06-22

Regulatory Status

Discontinued

2016
10 Aug
Discontinued Application: 204657

Drug Name

ESOMEPRAZOLE SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE/VIAL

Approval Date

2016-08-10

204657 / 1

Active Ingredient

ESOMEPRAZOLE SODIUM

Application Number

204657

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE/VIAL

Approval Date

2016-08-10

Regulatory Status

Discontinued

2016
10 Aug
Discontinued Application: 204657

Drug Name

ESOMEPRAZOLE SODIUM

Product Number

2

Dosage Form

-

Strength

EQ 40MG BASE/VIAL

Approval Date

2016-08-10

204657 / 2

Active Ingredient

ESOMEPRAZOLE SODIUM

Application Number

204657

Product Number

2

Dosage Form

-

Strength

EQ 40MG BASE/VIAL

Approval Date

2016-08-10

Regulatory Status

Discontinued

2019
23 Jul
Discontinued Application: 208811

Drug Name

FULVESTRANT

Product Number

1

Dosage Form

-

Strength

250MG/5ML (50MG/ML)

Approval Date

2019-07-23

208811 / 1

Active Ingredient

FULVESTRANT

Application Number

208811

Product Number

1

Dosage Form

-

Strength

250MG/5ML (50MG/ML)

Approval Date

2019-07-23

Regulatory Status

Discontinued

2023
30 Jun
Discontinued Application: 215169

Drug Name

FULVESTRANT

Product Number

1

Dosage Form

-

Strength

250MG/5ML (50MG/ML)

Approval Date

2023-06-30

215169 / 1

Active Ingredient

FULVESTRANT

Application Number

215169

Product Number

1

Dosage Form

-

Strength

250MG/5ML (50MG/ML)

Approval Date

2023-06-30

Regulatory Status

Discontinued

2024
08 Jan
Discontinued Application: 215236

Drug Name

GENTAMICIN SULFATE

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE/ML

Approval Date

2024-01-08

215236 / 1

Active Ingredient

GENTAMICIN SULFATE

Application Number

215236

Product Number

1

Dosage Form

-

Strength

EQ 10MG BASE/ML

Approval Date

2024-01-08

Regulatory Status

Discontinued

2018
28 Nov
Discontinued Application: 210244

Drug Name

GLYCOPYRROLATE

Product Number

1

Dosage Form

-

Strength

0.2MG/ML

Approval Date

2018-11-28

210244 / 1

Active Ingredient

GLYCOPYRROLATE

Application Number

210244

Product Number

1

Dosage Form

-

Strength

0.2MG/ML

Approval Date

2018-11-28

Regulatory Status

Discontinued

2016
06 Jul
Discontinued Application: 204238

Drug Name

GRANISETRON HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE/ML (EQ 1MG BASE/ML)

Approval Date

2016-07-06

204238 / 1

Active Ingredient

GRANISETRON HYDROCHLORIDE

Application Number

204238

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE/ML (EQ 1MG BASE/ML)

Approval Date

2016-07-06

Regulatory Status

Discontinued

2016
06 Jul
Discontinued Application: 204238

Drug Name

GRANISETRON HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 4MG BASE/4ML (EQ 1MG BASE/ML)

Approval Date

2016-07-06

204238 / 2

Active Ingredient

GRANISETRON HYDROCHLORIDE

Application Number

204238

Product Number

2

Dosage Form

-

Strength

EQ 4MG BASE/4ML (EQ 1MG BASE/ML)

Approval Date

2016-07-06

Regulatory Status

Discontinued

2019
09 May
Discontinued Application: 211142

Drug Name

HYDROXYPROGESTERONE CAPROATE

Product Number

1

Dosage Form

-

Strength

1250MG/5ML (250MG/ML)

Approval Date

2019-05-09

211142 / 1

Active Ingredient

HYDROXYPROGESTERONE CAPROATE

Application Number

211142

Product Number

1

Dosage Form

-

Strength

1250MG/5ML (250MG/ML)

Approval Date

2019-05-09

Regulatory Status

Discontinued

2021
09 Feb
Discontinued Application: 211864

Drug Name

ISOPROTERENOL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

0.2MG/ML

Approval Date

2021-02-09

211864 / 1

Active Ingredient

ISOPROTERENOL HYDROCHLORIDE

Application Number

211864

Product Number

1

Dosage Form

-

Strength

0.2MG/ML

Approval Date

2021-02-09

Regulatory Status

Discontinued

2020
03 Dec
Discontinued Application: 205190

Drug Name

KETOROLAC TROMETHAMINE

Product Number

1

Dosage Form

-

Strength

0.5%

Approval Date

2020-12-03

205190 / 1

Active Ingredient

KETOROLAC TROMETHAMINE

Application Number

205190

Product Number

1

Dosage Form

-

Strength

0.5%

Approval Date

2020-12-03

Regulatory Status

Discontinued

2018
15 Nov
Discontinued Application: 205191

Drug Name

KETOROLAC TROMETHAMINE

Product Number

1

Dosage Form

-

Strength

0.4%

Approval Date

2018-11-15

205191 / 1

Active Ingredient

KETOROLAC TROMETHAMINE

Application Number

205191

Product Number

1

Dosage Form

-

Strength

0.4%

Approval Date

2018-11-15

Regulatory Status

Discontinued

2020
20 Oct
Discontinued Application: 212939

Drug Name

KETOROLAC TROMETHAMINE

Product Number

1

Dosage Form

-

Strength

15MG/ML

Approval Date

2020-10-20

212939 / 1

Active Ingredient

KETOROLAC TROMETHAMINE

Application Number

212939

Product Number

1

Dosage Form

-

Strength

15MG/ML

Approval Date

2020-10-20

Regulatory Status

Discontinued

2020
20 Oct
Discontinued Application: 212939

Drug Name

KETOROLAC TROMETHAMINE

Product Number

2

Dosage Form

-

Strength

30MG/ML

Approval Date

2020-10-20

212939 / 2

Active Ingredient

KETOROLAC TROMETHAMINE

Application Number

212939

Product Number

2

Dosage Form

-

Strength

30MG/ML

Approval Date

2020-10-20

Regulatory Status

Discontinued

2019
03 Sep
Discontinued Application: 206519

Drug Name

LATANOPROST

Product Number

1

Dosage Form

-

Strength

0.005%

Approval Date

2019-09-03

206519 / 1

Active Ingredient

LATANOPROST

Application Number

206519

Product Number

1

Dosage Form

-

Strength

0.005%

Approval Date

2019-09-03

Regulatory Status

Discontinued

2013
24 Jan
Discontinued Application: 202328

Drug Name

LEVOFLOXACIN

Product Number

1

Dosage Form

-

Strength

EQ 500MG/20ML (EQ 25MG/ML)

Approval Date

2013-01-24

202328 / 1

Active Ingredient

LEVOFLOXACIN

Application Number

202328

Product Number

1

Dosage Form

-

Strength

EQ 500MG/20ML (EQ 25MG/ML)

Approval Date

2013-01-24

Regulatory Status

Discontinued

2013
24 Jan
Discontinued Application: 202328

Drug Name

LEVOFLOXACIN

Product Number

2

Dosage Form

-

Strength

EQ 750MG/30ML (EQ 25MG/ML)

Approval Date

2013-01-24

202328 / 2

Active Ingredient

LEVOFLOXACIN

Application Number

202328

Product Number

2

Dosage Form

-

Strength

EQ 750MG/30ML (EQ 25MG/ML)

Approval Date

2013-01-24

Regulatory Status

Discontinued

2016
10 Feb
Discontinued Application: 206919

Drug Name

LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER

Product Number

1

Dosage Form

-

Strength

EQ 250MG/50ML (EQ 5MG/ML)

Approval Date

2016-02-10

206919 / 1

Active Ingredient

LEVOFLOXACIN

Application Number

206919

Product Number

1

Dosage Form

-

Strength

EQ 250MG/50ML (EQ 5MG/ML)

Approval Date

2016-02-10

Regulatory Status

Discontinued

2016
10 Feb
Discontinued Application: 206919

Drug Name

LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER

Product Number

2

Dosage Form

-

Strength

EQ 500MG/100ML (EQ 5MG/ML)

Approval Date

2016-02-10

206919 / 2

Active Ingredient

LEVOFLOXACIN

Application Number

206919

Product Number

2

Dosage Form

-

Strength

EQ 500MG/100ML (EQ 5MG/ML)

Approval Date

2016-02-10

Regulatory Status

Discontinued

2016
10 Feb
Discontinued Application: 206919

Drug Name

LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER

Product Number

3

Dosage Form

-

Strength

EQ 750MG/150ML (EQ 5MG/ML)

Approval Date

2016-02-10

206919 / 3

Active Ingredient

LEVOFLOXACIN

Application Number

206919

Product Number

3

Dosage Form

-

Strength

EQ 750MG/150ML (EQ 5MG/ML)

Approval Date

2016-02-10

Regulatory Status

Discontinued

2013
14 Mar
Discontinued Application: 203040

Drug Name

LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE

Product Number

1

Dosage Form

-

Strength

1%

Approval Date

2013-03-14

203040 / 1

Active Ingredient

LIDOCAINE HYDROCHLORIDE

Application Number

203040

Product Number

1

Dosage Form

-

Strength

1%

Approval Date

2013-03-14

Regulatory Status

Discontinued

2013
14 Mar
Discontinued Application: 203040

Drug Name

LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE

Product Number

2

Dosage Form

-

Strength

2%

Approval Date

2013-03-14

203040 / 2

Active Ingredient

LIDOCAINE HYDROCHLORIDE

Application Number

203040

Product Number

2

Dosage Form

-

Strength

2%

Approval Date

2013-03-14

Regulatory Status

Discontinued

2023
07 Nov
Discontinued Application: 215063

Drug Name

LIFITEGRAST

Product Number

1

Dosage Form

-

Strength

5%

Approval Date

2023-11-07

215063 / 1

Active Ingredient

LIFITEGRAST

Application Number

215063

Product Number

1

Dosage Form

-

Strength

5%

Approval Date

2023-11-07

Regulatory Status

Discontinued

2015
15 Dec
Discontinued Application: 207667

Drug Name

METHYLPREDNISOLONE SODIUM SUCCINATE

Product Number

1

Dosage Form

-

Strength

EQ 40MG BASE/VIAL

Approval Date

2015-12-15

207667 / 1

Active Ingredient

METHYLPREDNISOLONE SODIUM SUCCINATE

Application Number

207667

Product Number

1

Dosage Form

-

Strength

EQ 40MG BASE/VIAL

Approval Date

2015-12-15

Regulatory Status

Discontinued

2015
15 Dec
Discontinued Application: 207667

Drug Name

METHYLPREDNISOLONE SODIUM SUCCINATE

Product Number

2

Dosage Form

-

Strength

EQ 125MG BASE/VIAL

Approval Date

2015-12-15

207667 / 2

Active Ingredient

METHYLPREDNISOLONE SODIUM SUCCINATE

Application Number

207667

Product Number

2

Dosage Form

-

Strength

EQ 125MG BASE/VIAL

Approval Date

2015-12-15

Regulatory Status

Discontinued

2015
15 Dec
Discontinued Application: 207667

Drug Name

METHYLPREDNISOLONE SODIUM SUCCINATE

Product Number

3

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2015-12-15

207667 / 3

Active Ingredient

METHYLPREDNISOLONE SODIUM SUCCINATE

Application Number

207667

Product Number

3

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2015-12-15

Regulatory Status

Discontinued

2015
15 Dec
Discontinued Application: 207667

Drug Name

METHYLPREDNISOLONE SODIUM SUCCINATE

Product Number

4

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2015-12-15

207667 / 4

Active Ingredient

METHYLPREDNISOLONE SODIUM SUCCINATE

Application Number

207667

Product Number

4

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2015-12-15

Regulatory Status

Discontinued

2023
30 Oct
Discontinued Application: 216732

Drug Name

MITOMYCIN

Product Number

1

Dosage Form

-

Strength

5MG/VIAL

Approval Date

2023-10-30

216732 / 1

Active Ingredient

MITOMYCIN

Application Number

216732

Product Number

1

Dosage Form

-

Strength

5MG/VIAL

Approval Date

2023-10-30

Regulatory Status

Discontinued

2023
30 Oct
Discontinued Application: 216732

Drug Name

MITOMYCIN

Product Number

2

Dosage Form

-

Strength

20MG/VIAL

Approval Date

2023-10-30

216732 / 2

Active Ingredient

MITOMYCIN

Application Number

216732

Product Number

2

Dosage Form

-

Strength

20MG/VIAL

Approval Date

2023-10-30

Regulatory Status

Discontinued

2023
30 Oct
Discontinued Application: 216732

Drug Name

MITOMYCIN

Product Number

3

Dosage Form

-

Strength

40MG/VIAL

Approval Date

2023-10-30

216732 / 3

Active Ingredient

MITOMYCIN

Application Number

216732

Product Number

3

Dosage Form

-

Strength

40MG/VIAL

Approval Date

2023-10-30

Regulatory Status

Discontinued

2019
15 Oct
Discontinued Application: 212455

Drug Name

NALOXONE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

0.4MG/ML

Approval Date

2019-10-15

212455 / 1

Active Ingredient

NALOXONE HYDROCHLORIDE

Application Number

212455

Product Number

1

Dosage Form

-

Strength

0.4MG/ML

Approval Date

2019-10-15

Regulatory Status

Discontinued

2023
02 Nov
Discontinued Application: 213244

Drug Name

NEOSTIGMINE METHYLSULFATE

Product Number

1

Dosage Form

-

Strength

5MG/10ML (0.5MG/ML)

Approval Date

2023-11-02

213244 / 1

Active Ingredient

NEOSTIGMINE METHYLSULFATE

Application Number

213244

Product Number

1

Dosage Form

-

Strength

5MG/10ML (0.5MG/ML)

Approval Date

2023-11-02

Regulatory Status

Discontinued

2023
02 Nov
Discontinued Application: 213244

Drug Name

NEOSTIGMINE METHYLSULFATE

Product Number

2

Dosage Form

-

Strength

10MG/10ML (1MG/ML)

Approval Date

2023-11-02

213244 / 2

Active Ingredient

NEOSTIGMINE METHYLSULFATE

Application Number

213244

Product Number

2

Dosage Form

-

Strength

10MG/10ML (1MG/ML)

Approval Date

2023-11-02

Regulatory Status

Discontinued

2012
21 Dec
Discontinued Application: 202599

Drug Name

ONDANSETRON HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 2MG BASE/ML

Approval Date

2012-12-21

202599 / 1

Active Ingredient

ONDANSETRON HYDROCHLORIDE

Application Number

202599

Product Number

1

Dosage Form

-

Strength

EQ 2MG BASE/ML

Approval Date

2012-12-21

Regulatory Status

Discontinued

2012
21 Dec
Discontinued Application: 202600

Drug Name

ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE

Product Number

1

Dosage Form

-

Strength

EQ 2MG BASE/ML

Approval Date

2012-12-21

202600 / 1

Active Ingredient

ONDANSETRON HYDROCHLORIDE

Application Number

202600

Product Number

1

Dosage Form

-

Strength

EQ 2MG BASE/ML

Approval Date

2012-12-21

Regulatory Status

Discontinued

2017
06 Sep
Discontinued Application: 205529

Drug Name

OXALIPLATIN

Product Number

1

Dosage Form

-

Strength

50MG/10ML (5MG/ML)

Approval Date

2017-09-06

205529 / 1

Active Ingredient

OXALIPLATIN

Application Number

205529

Product Number

1

Dosage Form

-

Strength

50MG/10ML (5MG/ML)

Approval Date

2017-09-06

Regulatory Status

Discontinued

2017
06 Sep
Discontinued Application: 205529

Drug Name

OXALIPLATIN

Product Number

2

Dosage Form

-

Strength

100MG/20ML (5MG/ML)

Approval Date

2017-09-06

205529 / 2

Active Ingredient

OXALIPLATIN

Application Number

205529

Product Number

2

Dosage Form

-

Strength

100MG/20ML (5MG/ML)

Approval Date

2017-09-06

Regulatory Status

Discontinued

2018
09 Oct
Discontinued Application: 205982

Drug Name

PARICALCITOL

Product Number

1

Dosage Form

-

Strength

0.002MG/ML (0.002MG/ML)

Approval Date

2018-10-09

205982 / 1

Active Ingredient

PARICALCITOL

Application Number

205982

Product Number

1

Dosage Form

-

Strength

0.002MG/ML (0.002MG/ML)

Approval Date

2018-10-09

Regulatory Status

Discontinued

2018
09 Oct
Discontinued Application: 205982

Drug Name

PARICALCITOL

Product Number

2

Dosage Form

-

Strength

0.005MG/ML (0.005MG/ML)

Approval Date

2018-10-09

205982 / 2

Active Ingredient

PARICALCITOL

Application Number

205982

Product Number

2

Dosage Form

-

Strength

0.005MG/ML (0.005MG/ML)

Approval Date

2018-10-09

Regulatory Status

Discontinued

2018
09 Oct
Discontinued Application: 205982

Drug Name

PARICALCITOL

Product Number

3

Dosage Form

-

Strength

0.01MG/2ML (0.005MG/ML)

Approval Date

2018-10-09

205982 / 3

Active Ingredient

PARICALCITOL

Application Number

205982

Product Number

3

Dosage Form

-

Strength

0.01MG/2ML (0.005MG/ML)

Approval Date

2018-10-09

Regulatory Status

Discontinued

2023
12 Oct
Discontinued Application: 217409

Drug Name

PIPERACILLIN AND TAZOBACTAM

Product Number

1

Dosage Form

-

Strength

EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL

Approval Date

2023-10-12

217409 / 1

Active Ingredient

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Application Number

217409

Product Number

1

Dosage Form

-

Strength

EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL

Approval Date

2023-10-12

Regulatory Status

Discontinued

2023
12 Oct
Discontinued Application: 217409

Drug Name

PIPERACILLIN AND TAZOBACTAM

Product Number

2

Dosage Form

-

Strength

EQ 12GM BASE/VIAL;EQ 1.5GM BASE/VIAL

Approval Date

2023-10-12

217409 / 2

Active Ingredient

PIPERACILLIN SODIUM; TAZOBACTAM SODIUM

Application Number

217409

Product Number

2

Dosage Form

-

Strength

EQ 12GM BASE/VIAL;EQ 1.5GM BASE/VIAL

Approval Date

2023-10-12

Regulatory Status

Discontinued

2020
10 Dec
Discontinued Application: 211934

Drug Name

SODIUM NITROPRUSSIDE

Product Number

1

Dosage Form

-

Strength

25MG/ML

Approval Date

2020-12-10

211934 / 1

Active Ingredient

SODIUM NITROPRUSSIDE

Application Number

211934

Product Number

1

Dosage Form

-

Strength

25MG/ML

Approval Date

2020-12-10

Regulatory Status

Discontinued

2023
16 Oct
Discontinued Application: 217808

Drug Name

SUCCINYLCHOLINE CHLORIDE

Product Number

1

Dosage Form

-

Strength

20MG/ML

Approval Date

2023-10-16

217808 / 1

Active Ingredient

SUCCINYLCHOLINE CHLORIDE

Application Number

217808

Product Number

1

Dosage Form

-

Strength

20MG/ML

Approval Date

2023-10-16

Regulatory Status

Discontinued

2023
02 Feb
Discontinued Application: 212162

Drug Name

VORICONAZOLE

Product Number

1

Dosage Form

-

Strength

200MG/VIAL

Approval Date

2023-02-02

212162 / 1

Active Ingredient

VORICONAZOLE

Application Number

212162

Product Number

1

Dosage Form

-

Strength

200MG/VIAL

Approval Date

2023-02-02

Regulatory Status

Discontinued

2016
26 Sep
Discontinued Application: 207751

Drug Name

ZOLEDRONIC ACID

Product Number

1

Dosage Form

-

Strength

EQ 4MG BASE/5ML

Approval Date

2016-09-26

207751 / 1

Active Ingredient

ZOLEDRONIC ACID

Application Number

207751

Product Number

1

Dosage Form

-

Strength

EQ 4MG BASE/5ML

Approval Date

2016-09-26

Regulatory Status

Discontinued

2017
08 Dec
Discontinued Application: 209125

Drug Name

ZOLEDRONIC ACID

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE/100ML

Approval Date

2017-12-08

209125 / 1

Active Ingredient

ZOLEDRONIC ACID

Application Number

209125

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE/100ML

Approval Date

2017-12-08

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    256 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
71 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ALCAFTADINE

Application Number

210659

Product Number

1

Active Ingredient

ALCAFTADINE

Dosage Form

-

Strength

0.25%

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit